Acute monocytic leukemia (AMoL) is a type of acute myeloid leukemia (AML). It’s also known as AML-M5. It happens when immature cells that are on track to develop into white blood cells (monocytes) turn cancerous. The most common treatments are chemotherapy and stem cell transplants.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Acute monocytic leukemia (AMoL) is a type of acute myeloid leukemia (AML). Like all forms of leukemia, AMoL is a blood cancer. It happens when there’s a problem with blood cell development. Instead of becoming healthy blood cells, the still-developing cells transform into abnormal cancer cells.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
With AMoL, the immature cells, or blasts, are on a path to becoming white blood cells called monocytes. But instead, they get stuck in the immature or blast form.
Acute monocytic leukemia is a serious and aggressive cancer. Your healthcare provider will work with you to find the best treatments based on your situation.
The World Health Organization (WHO) classifies AMoL based on the type of cells that turn cancerous (monocytes). Acute monocytic leukemia is also known as AML-M5 according to the French-American-British (FAB) Classification system. This system further divides AML-M5 into two groups:
These classifications help healthcare providers diagnose the condition. But one type isn’t more serious than another.
Symptoms of AMoL are often noticeable and get worse fast. They include:
Advertisement
Acute monocytic leukemia can often involve your brain and central nervous system. If it does, you may notice related symptoms, like trouble remembering or focusing.
Medical experts don’t know what causes AMoL. But it likely involves genetic mutations (changes) in cell DNA. These changes cause a healthy cell to become cancerous.
Researchers have found that in some people with AMoL, there’s a mix-up involving genetic material called chromosomes. One piece of a chromosome breaks off and attaches to a different chromosome. This is called chromosomal translocation. The mix-up may cause a cell to stop developing into a monocyte and become a cancer cell instead.
Research into these gene changes is ongoing. Understanding the genetics behind cancer helps experts develop better treatments to fight it.
Factors that may increase your risk of acute monocytic leukemia include:
It’s important to remember that having a risk factor doesn’t mean you’ll get cancer. Still, it’s a good idea to avoid risks you can control, like choosing not to smoke.
With AMoL, too many abnormal cells can build up in your bone marrow. This is where blood cells get made. The cancer cells can crowd out your healthy blood cells. This can lead to low red blood cells, white blood cells and platelets, leading to complications like:
Healthcare providers use a series of tests to diagnose AMoL. According to the World Health Organization, a person has AMoL when 20% or more of their blood cells are abnormal, immature cells. More than 80% of the abnormal cells have to be monocytes or early forms of monocytes.
Your provider will draw blood or take samples of fluid, tissue or bone marrow. The actual analysis happens behind the in a lab.
Tests to diagnose AMoL include:
Advertisement
The goals of treatment are to put cancer into remission. This means you no longer have cancer cells in your bone marrow or blood. This isn’t the same as a cure, which means the cancer is gone and won’t come back.
Chemotherapy is the main treatment for acute monocytic leukemia. It involves:
This treatment targets specific mutations (changes) in cancer cells. You may need targeted therapy if chemotherapy hasn’t worked. Or you may get targeted therapy if the cancer cells have a specific genetic mutation that a targeted therapy drug treats.
The only way to cure acute monocytic leukemia is with an allogeneic stem cell transplant. You may need one after you are in remission. Or you may get a transplant if the cancer comes back after remission. During the procedure, a provider replaces your stem cells with stem cells from a donor. Usually, a donor is a close relative with a matching blood type. They may also be an unrelated donor from a national or international registry.
Advertisement
Not everyone is a candidate for a stem cell transplant. And it can cause serious side effects. Your healthcare provider can explain the benefits and risks if they’re recommending it.
A clinical trial is a study that tests the safety and effectiveness of new treatments. Depending on your diagnosis, it may be the best treatment for you. Ask your healthcare provider if they think you should participate in a clinical trial.
The outlook for acute monocytic leukemia (AMoL) is similar to acute myeloid leukemia in general (AML) in general. About 3 people in 10 with AMoL are alive five years after they’re diagnosed.
Still, it’s important to remember that these numbers don’t reflect new treatments. And new treatments are helping people live longer with AMoL. Also, your prognosis (likely outcome) depends on several factors, including your:
Living with leukemia is stressful. Even after remission, you may have to cope with concerns that the cancer may come back. You may have to manage long-term side effects of cancer treatment. The best way to take care of yourself is to take advantage of every available resource. This may include:
Advertisement
You’ll see your healthcare provider regularly to monitor your response to treatment. They’ll let you know what changes in your body to look out for that may be signs the cancer is coming back.
Questions to ask include:
Learning that you or your child has acute monocytic leukemia (AMoL) can feel jarring. Blood cancers are serious, and treatments tend to be aggressive. You may be dealing with several treatment sessions in the days, weeks and months ahead.
It’s important to remember that these treatments are helping people live longer than ever. For some, treatment gets rid of the cancer for good. Ask your healthcare provider what outcomes you can expect. Have them explain the benefits and potential risks of all of your treatment options. They can help you handle what comes next.
A leukemia diagnosis can come as quite a shock. Cleveland Clinic’s blood cancer experts are here to guide you through it and help you move forward.
Last reviewed on 03/17/2025.
Learn more about the Health Library and our editorial process.